Fosun December 29 announcement that the mutually beneficial aspects of the company and the U.S. signed a "joint venture contract," according to the contract,digital thermometer the partnership will be completed in two stages.
The first phase, completed a joint venture formed ChindexMedical Fosun Pharmaceutical companies wholly-owned Sun Yue the company invested 20 million U.S. dollars accounted for 51% stake in wholly-owned subsidiary of Chindex ChindexMedicalHoldings 49% of the shares, clinical thermometer the stage of delivery is expected to be December 31, ear thermometer 2010 to complete.
The second stage, digital blood pressure monitor Fosun Pharmaceutical business of its medical device innovation and technology investment and management platform by 100% equity into the joint venture related to the transfer process ChindexMedical, medicine and the United States to achieve mutually beneficial Fosun all of its medical equipment business integration, the second phase of delivery the second quarter of 2011 is expected to be completed.
Statistics show that the U.S. is mutually beneficial for the Chinese market, a healthcare services and supplies medical equipment, American healthcare company. The joint venture will continue to sell the products of the large multinational companies, but also will be the color Doppler ultrasound, mammography, cosmetic laser and surgical robot distribution partners, and will continue to hospitals in China for the purchase of medical equipment and the U.S. Export-Import Bank Germany's KfW development bank loans business.
Transactions, will enable both companies and the United States and mutually beneficial integration of the existing medical device business, the company will further improve the medical device business from R & D, manufacturing to domestic and international marketing of the whole industry chain, to further accelerate the development of medical devices business; ChindexMedical and The companies under the holding company will be included in the consolidated statements.